Induction of Cytokine Expression by Leukemia Inhibitory Factor

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1993 Apr 1

PMID 8473500

Citations 21

Authors

P M Villiger

Y Geng

M Lotz

Affiliations

Soon will be listed here.

Abstract

Biological effects of cytokines are in part determined by their interactions in the regulation of cytokine production. This study analyzes the effects of leukemia inhibitory factor (LIF) on cytokine expression in different cell lineages. Recombinant human LIF increases levels of IL-1 beta, IL-6, and IL-8 mRNA in human articular chondrocytes as demonstrated by Northern blotting. These cytokine mRNAs are detectable as early as 1.3 h after stimulation and reach their maximum after 5 h. The LIF effects are dose dependent and of similar magnitude to those of IL-1. By metabolic labeling and immunoprecipitation it is shown that LIF induces synthesis and secretion of IL-6. IL-6 bioactivity in conditioned media, as measured by the B9 hybridoma proliferation assay, is increased by LIF. Effects of LIF on cytokine expression are not confined to connective tissue cells. By PCR it is shown that human blood monocytes express IL-6 mRNA after stimulation with LIF. An increase in IL-6 mRNA levels is detectable 2 h after stimulation, and this starts to decline by 5 h. The response is of shorter duration as compared with IL-1 beta. In addition to increased mRNA expression, LIF also stimulates release of biologically active IL-6 from blood monocytes. In synoviocytes and neuronal as well as epithelial cell lines, LIF increases IL-1 beta and IL-6 gene expression. In summary, LIF induces cytokine expression in a wide variety of tissues. These results suggest that through the induction of cytokines, LIF can modulate inflammation, immune responses, and connective tissue metabolism, and act as a pathogenetic mediator in different disease states.

Citing Articles

gBLUP-GWAS identifies candidate genes, signaling pathways, and putative functional polymorphisms for age at puberty in gilts.

Wijesena H, Nonneman D, Snelling W, Rohrer G, Keel B, Lents C J Anim Sci. 2023; 101.

PMID: 36848325 PMC: 10016198. DOI: 10.1093/jas/skad063.

Transcriptomic analysis of the anti-inflammatory effect of extract on acute gouty arthritis.

Jiao C, Liang H, Liu L, Li S, Chen J, Xie Y Front Pharmacol. 2022; 13:1035101.

PMID: 36313318 PMC: 9614083. DOI: 10.3389/fphar.2022.1035101.

Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer.

Jorgensen M, de la Puente P Biomolecules. 2022; 12(2).

PMID: 35204717 PMC: 8961628. DOI: 10.3390/biom12020217.

Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells.

Lindkvist M, Zegeye M, Grenegard M, Ljungberg L Int J Mol Sci. 2022; 23(3).

PMID: 35163371 PMC: 8836206. DOI: 10.3390/ijms23031448.

Obesity, Neuroinflammation, and Reproductive Function.

Lainez N, Coss D Endocrinology. 2019; 160(11):2719-2736.

PMID: 31513269 PMC: 6806266. DOI: 10.1210/en.2019-00487.

References

Mizel S, Dayer J, Krane S, Mergenhagen S . Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A. 1981; 78(4):2474-7. PMC: 319369. DOI: 10.1073/pnas.78.4.2474. View

Lotz M, Moats T, Villiger P . Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest. 1992; 90(3):888-96. PMC: 329943. DOI: 10.1172/JCI115964. View

Tomida M, Hozumi M . Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem. 1984; 259(17):10978-82. View

Abe E, Tanaka H, Ishimi Y, Miyaura C, Hayashi T, Nagasawa H . Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci U S A. 1986; 83(16):5958-62. PMC: 386416. DOI: 10.1073/pnas.83.16.5958. View

Smith A, Hooper M . Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol. 1987; 121(1):1-9. DOI: 10.1016/0012-1606(87)90132-1. View

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Godard A, Gascan H, Naulet J, Peyrat M, Jacques Y, Soulillou J . Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood. 1988; 71(6):1618-23. View

Hilton D, Nicola N, Gough N, Metcalf D . Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines. J Biol Chem. 1988; 263(19):9238-43. View

Hilton D, Nicola N, Metcalf D . Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells. Proc Natl Acad Sci U S A. 1988; 85(16):5971-5. PMC: 281887. DOI: 10.1073/pnas.85.16.5971. View

10.

Williams R, Hilton D, Pease S, Willson T, Stewart C, Gearing D . Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 1988; 336(6200):684-7. DOI: 10.1038/336684a0. View

11.

Smith A, Heath J, Donaldson D, Wong G, Moreau J, Stahl M . Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature. 1988; 336(6200):688-90. DOI: 10.1038/336688a0. View

12.

Guerne P, Zuraw B, Vaughan J, Carson D, Lotz M . Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest. 1989; 83(2):585-92. PMC: 303718. DOI: 10.1172/JCI113921. View

13.

Metcalf D . Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia. 1989; 3(5):349-55. View

14.

Mori M, Yamaguchi K, Abe K . Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun. 1989; 160(3):1085-92. DOI: 10.1016/s0006-291x(89)80114-7. View

15.

Baumann H, Wong G . Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol. 1989; 143(4):1163-7. View

16.

Metcalf D, Gearing D . Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci U S A. 1989; 86(15):5948-52. PMC: 297748. DOI: 10.1073/pnas.86.15.5948. View

17.

Yamamori T, Fukada K, Aebersold R, Korsching S, Fann M, Patterson P . The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science. 1989; 246(4936):1412-6. DOI: 10.1126/science.2512641. View

18.

Guerne P, Carson D, Lotz M . IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol. 1990; 144(2):499-505. View

19.

REID L, Lowe C, Cornish J, Skinner S, Hilton D, Willson T . Leukemia inhibitory factor: a novel bone-active cytokine. Endocrinology. 1990; 126(3):1416-20. DOI: 10.1210/endo-126-3-1416. View

20.

Gascan H, Anegon I, Praloran V, Naulet J, Godard A, Soulillou J . Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol. 1990; 144(7):2592-8. View